Study demonstrated a dose dependant reduction of
carragennan-induced rat paw edema by the CJSPE.
Moreover, significant (p < 0.001) anti-inflammatory activity
was displayed by CJSPE (dose 200 mg/kg) in the late phase of inflammation; and effect was comparable to that of diclofenac sodium